Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
International Journal of Clinical Pharmacy
Published in: International Journal of Clinical Pharmacy 6/2019

01-12-2019 | Commentary

Prescriptome analytics: an opportunity for clinical pharmacy

Author: Pascal A. Le Corre

Published in: International Journal of Clinical Pharmacy | Issue 6/2019

Login to get access

Abstract

Clinical pharmacists have unique opportunities to be more involved in prescriptome analytics to expand research horizon in clinical pharmacy as an academic discipline. The development of predictive analytics with machine learning algorithms could have the potential to redesign the way we care for patients in our institutions for a more personalized medication therapy.
Literature
1.
Carter BL. Have we been true to Paul Parker's vision? Paul F. Parker Medal for distinguished service to the profession of pharmacy remarks. J Am Coll Clin Pharm. 2019;2:92–4.CrossRef
2.
Bouzillé G, Westerlynck R, Defossez G, Bouslimi D, Bayat S, Riou C, et al. Sharing health big data for research: a design by use cases: the INSHARE platform approach. Stud Health Technol Inform. 2017;245:303–7.PubMed
3.
4.
Shameer K, Perez-Rodriguez MM, Bachar R, Li L, Johnson A, Johnson KW, et al. Pharmacological risk factors associated with hospital readmission rates in a psychiatric cohort identified using prescriptome data mining. BMC Med Inform Decis Mak. 2018;18(Suppl 3):1–11.
5.
Hansen PW, Clemmensen L, Sehested TS, Fosbøl EL, Torp-Pedersen C, Køber L, et al. Identifying drug-drug interactions by data mining: a pilot study of warfarin-associated drug interactions. Circ Cardiovasc Qual Outcomes. 2016;9:621–8.CrossRef
6.
Morival C, Westerlynck R, Bouzillé G, Cuggia M, Le Corre P. Prevalence and nature of statin drug-drug interactions in a university hospital by electronic health record mining. Eur J Clin Pharmacol. 2018;74:525–34.CrossRef
7.
Hart E, Dunn TE, Feuerstein S, Jacobs DM. Proton pump inhibitors and risk of acute and chronic kidney disease: a retrospective cohort study. Pharmacotherapy. 2019;39:443–53.CrossRef
8.
Baro E, Degoul S, Beuscart R, Chazard E. Toward a literature-driven definition of big data in healthcare. Biomed Res Int. 2015;2:1–9.CrossRef
9.
Shameer K, Johnson KW, Yahi A, Miotto R, Li LI, Ricks D, et al. Predictive modeling of hospital readmission rates using electronic medical record-wide machine learning: a case-study using mount sinai heart failure cohort. Pac Symp Biocomput. 2017;22:276–87.PubMed
10.
Lo-Ciganic WH, Huang JL, Zhang HH, Weiss JC, Wu Y, Kwoh CK, et al. Evaluation of machine-learning algorithms for predicting opioid overdose risk among medicare beneficiaries with opioid prescriptions. JAMA Netw Open. 2019;2:1–15.CrossRef
11.
Adam TJ, Chi CL. Big data cohort extraction for personalized statin treatment and machine learning. Methods Mol Biol. 2019;1939:255–72.CrossRef
12.
Fröhlich H, Balling R, Beerenwinkel N, Kohlbacher O, Kumar S, Lengauer T, et al. From hype to reality: data science enabling personalized medicine. BMC Med. 2018;16(1):150–65.CrossRef
13.
Winn AN, Neuner JM. Making sure we don't forget the basics when using machine learning. J Natl Cancer Inst. 2019;111(6):529–30.CrossRef
14.
Mazzocchi F. Could big data be the end of theory in science? A few remarks on the epistemology of data-driven science. EMBO Rep. 2015;16:1250–5.CrossRef
Metadata
Title
Prescriptome analytics: an opportunity for clinical pharmacy
Author
Pascal A. Le Corre
Publication date
01-12-2019
Publisher
Springer International Publishing
Published in
International Journal of Clinical Pharmacy / Issue 6/2019
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-019-00900-9

Other articles of this Issue 6/2019

International Journal of Clinical Pharmacy 6/2019 Go to the issue

Research Article

Interdisciplinary medication review to improve pharmacotherapy for patients with intellectual disabilities

Research Article

Assessing risk of adverse drug reactions in the elderly: a feasibility study

Research Article

Community pharmacists’ clinical reasoning: a protocol analysis

Research Article

Preventability analysis of adverse drug reactions in a Jordanian hospital: a prospective observational study

Research Article

Evaluation of a pharmacist-led antimicrobial stewardship service in a pediatric emergency department

Research Article

Identification and resolution of drug-related problems in a tertiary hospital respiratory unit in China
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits